Teva Pharmaceutical Industries Limited (TEVA) Receives Buy Rating from Gabelli
's stock had its "buy" rating reiterated by research analysts at Gabelli in a note issued to investors on Monday. A number of other research analysts have also weighed in on the company.
from Biotech News
0 Comments